Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| 1 |
Walt Disney
DIS
|
+$651M |
| 2 |
Coty
COTY
|
+$463M |
| 3 |
ConocoPhillips
COP
|
+$248M |
| 4 |
Zimmer Biomet
ZBH
|
+$232M |
| 5 |
Valero Energy
VLO
|
+$175M |
Top Sells
| 1 |
Apple
AAPL
|
+$586M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$324M |
| 5 |
CELG
Celgene Corp
CELG
|
+$308M |
Sector Composition
| 1 | Healthcare | 14.85% |
| 2 | Technology | 12.61% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
676
BOK Financial
BOKF
$7.02B
| $20.7M | 0.03% |
254,262
+179,332
| +239% | +$14.6M |
|
677
American International
AIG
$43.2B
| $20.7M | 0.03% |
481,255
+192,424
| +67% | +$8.29M |
|
678
Helix Energy Solutions
HLX
$923M
| $20.6M | 0.03% |
2,603,190
-844,867
| -25% | -$6.68M |
|
679
Penumbra
PEN
$10.6B
| $20.6M | 0.03% |
139,902
-34,771
| -20% | -$5.11M |
|
680
Usana Health Sciences
USNA
$551M
| $20.5M | 0.03% |
244,610
+130,657
| +115% | +$11M |
|
681
Veracyte
VCYT
$2.42B
| $20.5M | 0.03% |
819,227
-599,059
| -42% | -$15M |
|
682
Schneider National
SNDR
$4.18B
| $20.5M | 0.03% |
972,391
-417,310
| -30% | -$8.78M |
|
683
Cheniere Energy
LNG
$52.1B
| $20.5M | 0.03% |
299,402
-1,425,869
| -83% | -$97.5M |
|
684
Olin
OLN
$2.92B
| $20.3M | 0.03% |
879,228
-1,606,181
| -65% | -$37.2M |
|
685
PTC Therapeutics
PTCT
$4.63B
| $20.3M | 0.03% |
538,001
+374,690
| +229% | +$14.1M |
|
686
Hanover Insurance
THG
$6.37B
| $20.2M | 0.03% |
177,241
-11,259
| -6% | -$1.29M |
|
687
Cigna
CI
$80.7B
| $20.1M | 0.03% |
125,281
-504,457
| -80% | -$81.1M |
|
688
PENN Entertainment
PENN
$2.93B
| $20.1M | 0.03% |
1,001,667
+883,171
| +745% | +$17.8M |
|
689
Rayonier
RYN
$4.04B
| $20.1M | 0.03% |
670,698
+151,614
| +29% | +$4.55M |
|
690
Bank of Hawaii
BOH
$2.7B
| $20M | 0.03% |
253,720
+187,482
| +283% | +$14.8M |
|
|
DHR.PRA
691
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
| $19.9M | 0.03% |
+18,963
| New | +$19.9M |
|
692
Brunswick
BC
$4.23B
| $19.9M | 0.03% |
395,927
+325,861
| +465% | +$16.4M |
|
693
Pacific Biosciences
PACB
$366M
| $19.7M | 0.03% |
2,730,462
+64,374
| +2% | +$465K |
|
694
Fair Isaac
FICO
$36.7B
| $19.7M | 0.03% |
72,433
-90,027
| -55% | -$24.5M |
|
695
Allete
ALE
$3.7B
| $19.7M | 0.03% |
239,180
+221,728
| +1,271% | +$18.2M |
|
|
GMHIU
696
DELISTED
Gores Metropoulos, Inc. Unit
GMHIU
| $19.7M | 0.03% |
+1,920,000
| New | +$19.7M |
|
|
LXFT
697
DELISTED
Luxoft Holding, Inc.
LXFT
| $19.5M | 0.03% |
332,939
+271,296
| +440% | +$15.9M |
|
698
Banco Macro
BMA
$3.03B
| $19.5M | 0.03% |
426,946
+2,261
| +0.5% | +$103K |
|
|
HZNP
699
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $19.5M | 0.03% |
737,629
-141,416
| -16% | -$3.74M |
|
|
AZPN
700
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $19.4M | 0.03% |
186,327
-134,303
| -42% | -$14M |
|